EMEA-001810-PIP01-15

Key facts

Active substance
L-Cysteine, L-leucyl-L-α-glutamyl-L-α-glutamyl-L-lysyl-L-lysylglycyl-L-asparaginyl-L-tyrosyl-L-valyl-L-valyl-L-threonyl-L-α -aspartyl-L-histidyl-S-[1-[(4-carboxycyclohexyl)methyl]-2,5-dioxo-3-pyrrolidinyl]-, complex with keyhole limpet haemocyanin
Therapeutic area
Oncology
Decision number
P/0259/2015
PIP number
EMEA-001810-PIP01-15
Pharmaceutical form(s)
Powder for solution for injection
Condition(s) / indication(s)
Treatment of high-grade glioma
Route(s) of administration
Intradermal use
Contact for public enquiries
Celldex Therapeutics, Inc.
Germany
Tel. +1 7814 333111
Fax +1 7814 333133
E-mail: aelnatan@celldex.com
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating